Prognostic implications of ezrin expression in human hepatocellular carcinoma

Molecular Carcinogenesis

Volumn 49, Issue 9, 2010, Pages 798-804

  Kang, Yun Kyung ^a   Hong, Seong Woo ^a   Lee, Hyucksang ^a   Kim, Woo Ho ^b  

^a Inje University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Ezrin; Hepatocellular carcinoma; Immunohistochemistry; Protooncogene protein c Met; Survival analysis; Tissue array analysis

Indexed keywords

EZRIN; BIOLOGICAL MARKER; CADHERIN; CYTOSKELETON PROTEIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TISSUE MICROARRAY; TUMOR RECURRENCE; UNIVARIATE ANALYSIS; DISEASE COURSE; LIVER TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; NEOPLASM; PATHOLOGY;

ADULT; AGED; BIOLOGICAL MARKERS; CADHERINS; CARCINOMA, HEPATOCELLULAR; CYTOSKELETAL PROTEINS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; PROGNOSIS; YOUNG ADULT;

EID: 77956211588     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20653     Document Type: Article

References (27)

1. Bretscher A, Edwards K, Fehon RG. ERM proteins and merlin: Integrators at the cell cortex. Nat Rev Mol Cell Biol 2002;3:586-599.
2. Gautreau A, Poullet P, Louvard D, Arpin M. Ezrin, a plasma membrane-microfilament linker, signals cell survival through the phosphatidylinositol 3-kinase/Akt pathway. Proc Natl Acad Sci USA 1999;96:7300-7305. (Pubitemid 29299656)
3. Martin TA, Harrison G, Mansel RE, Jiang WG. The role of the CD44/ezrin complex in cancer metastasis. Crit Rev Oncol Hematol 2003;46:165-186.
4. Hunter KW. Ezrin, a key component in tumor metastasis. Trends Mol Med 2004;10:201-204.
5. Khanna C, Wan X, Bose S, et al. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 2004;10:182-186.
6. Elliott BE, Meens JA, SenGupta SK, Louvard D, Arpin M. The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells. Breast Cancer Res 2005;7:R365-R373.
7. Madan R, Brandwein-Gensler M, Schlecht NF, et al. Differential tissue and subcellular expression of ERM proteins in normal and malignant tissues: Cytoplasmic ezrin expression has prognostic significance for head and neck squamous cell carcinoma. Head Neck 2006;28:1018-1027.
8. Akisawa N, Nishimori I, Iwamura T, Onishi S, Hollingsworth MA. High levels of ezrin expressed by human pancreatic adenocarcinoma cell lines with high metastatic potential. Biochem Biophys Res Commun 1999;258:395-400. (Pubitemid 29287062)
9. Yeh TS, Tseng JH, Liu NJ, Chen TC, Jan YY, Chen MF. Significance of cellular distribution of ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma. Arch Surg 2005;140:1184-1190.
10. Hustinx SR, Fukushima N, Zahurak ML, et al. Expression and prognostic significance of 14-3-3σ and ERM family protein expression in periampullary neoplasms. Cancer Biol Ther 2005;4:596-601.
11. Bal N, Yildirim S, Nursal TZ, Bolat F, Kayaselcuk F. Association of ezrin expression in intestinal and diffuse gastric carcinoma with clinicopathological parameters and tumor type. World J Gastroenterol 2007;13:3726-3729.
12. Elzagheid A, Korkeila E, Bendardaf R, et al. Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer. Hum Pathol 2008;39:1737-1743.
13. Weng WH, Åhlén J, Åström K, Lui WO, Larsson C. Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas. Clin Cancer Res 2005;11:6198-6204.
14. Bruce B, Khanna G, Ren L, et al. Expression of the cytoskeleton linker protein ezrin in human cancers. Clin Exp Metastasis 2007;24:69-78.
15. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-750. (Pubitemid 29114292)
16. Headquaters of the Korea Central Cancer Registry, Ministry of Health and Welfare, Republic of Korea. Annual Report of the Korea Central Cancer Registry Program, Based on Registered Data From 131 Hospitals. 2002. pp 12-13.
17. Lara-Pezzi E, Serrador JM, Montoya MC, et al. The hepatitis B virus X protein (HBx) induces a migratory phenotype in a CD44-dependent manner: Possible role of HBx in invasion and metastasis. Hepatology 2001;33:1270-1281.
18. Zhang Y, Hu MY, Wu WZ, et al. The membrane-cytoskeleton organizer ezrin is necessary for hepatocellular carcinoma cell growth and invasiveness. J Cancer Res Clin Oncol 2006;132:685-697.
19. Okamura D, Ohtsuka M, Kimura F, et al. Ezrin expression is associated with hepatocellular carcinoma possibly derived from progenitor cells and early recurrence after surgical resection. Mod Pathol 2008;21:847-855.
20. Mathew J, Hines JE, Obafunwa JO, Burr AW, Toole K, Burt AD. CD44 is expressed in hepatocellular carcinomas showing vascular invasion. J Pathol 1996;179:74-79. (Pubitemid 26182868)
21. Ueki T, Fujimoto J, Suzuki T, Yamamoto H, Okamoto E. Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma. Hepatology 1997;25:862-866. (Pubitemid 27157127)
22. Matsumura T, Makino R, Mitamura K. Frequent downregulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas. Clin Cancer Res 2001;7:594-599.
23. American Joint Committee on Cancer. AJCC Cancer Staging Manual. New York: Springer; 2002. 133 p.
24. Wielenga VJ, van der Voort R, Taher TE, et al. Expression of c-Met and heparan-sulfate proteoglycan forms of CD44 in colorectal cancer. Am J Pathol 2000;157:1563-1573.
25. Kanai Y, Ushijima S, Hui AM, et al. The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int J Cancer 1997;71:355-359.
26. Lee JS, Heo J, Libbrecht L, et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med 2006;12:410-416.
27. Crepaldi T, Gautreau A, Comoglio PM, Louvard D, Arpin M. Ezrin in an effector of hepatocyte growth factor-mediated migration and morphogenesis in epithelial cells. J Cell Biol 1997;138:423-434. (Pubitemid 27323543)